BidaskClub Lowers Neptune Wellness Solutions (NASDAQ:NEPT) to Sell

BidaskClub cut shares of Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) from a hold rating to a sell rating in a research note issued to investors on Saturday, BidAskClub reports.

Separately, Zacks Investment Research downgraded shares of Neptune Wellness Solutions from a hold rating to a sell rating in a research report on Friday, June 12th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of Hold and a consensus target price of $4.63.

Shares of NASDAQ:NEPT opened at $2.93 on Friday. Neptune Wellness Solutions has a 52 week low of $0.96 and a 52 week high of $6.57. The company’s 50 day moving average is $2.81 and its two-hundred day moving average is $2.28. The company has a current ratio of 2.25, a quick ratio of 1.73 and a debt-to-equity ratio of 0.01. The company has a market cap of $300.60 million, a PE ratio of -5.98 and a beta of 2.72.

Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) last announced its quarterly earnings data on Wednesday, June 10th. The biotechnology company reported ($0.21) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.08) by ($0.13). Neptune Wellness Solutions had a negative net margin of 204.83% and a negative return on equity of 51.03%. The firm had revenue of $7.11 million during the quarter, compared to analysts’ expectations of $6.32 million. As a group, equities research analysts expect that Neptune Wellness Solutions will post -0.13 EPS for the current year.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Two Sigma Investments LP purchased a new position in shares of Neptune Wellness Solutions in the 1st quarter valued at $64,000. Deutsche Bank AG grew its position in shares of Neptune Wellness Solutions by 333.2% in the 1st quarter. Deutsche Bank AG now owns 231,664 shares of the biotechnology company’s stock valued at $271,000 after buying an additional 178,192 shares during the last quarter. White Pine Capital LLC grew its position in shares of Neptune Wellness Solutions by 55.7% in the 1st quarter. White Pine Capital LLC now owns 117,932 shares of the biotechnology company’s stock valued at $138,000 after buying an additional 42,200 shares during the last quarter. AdvisorShares Investments LLC grew its position in shares of Neptune Wellness Solutions by 9.2% in the 1st quarter. AdvisorShares Investments LLC now owns 395,607 shares of the biotechnology company’s stock valued at $463,000 after buying an additional 33,426 shares during the last quarter. Finally, Penserra Capital Management LLC grew its position in shares of Neptune Wellness Solutions by 44.6% in the 4th quarter. Penserra Capital Management LLC now owns 67,472 shares of the biotechnology company’s stock valued at $153,000 after buying an additional 20,810 shares during the last quarter. 16.85% of the stock is currently owned by hedge funds and other institutional investors.

Neptune Wellness Solutions Company Profile

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.

Featured Article: Yield Curve

Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.